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Abstract 
Two population-based surveys on COVID-19 like symptoms were conducted by BVA-Doxa on representative 
samples of the general population from Italy and its largest region, Lombardy, with over 10 million inhabitants 
and heavily struck by COVID19,  on March 27-30 and April 3-7, on a total of 2000 individuals – 353 from 
Lombardy. Overall, 14.2% of Italians – and 19.6%  in Lombardy – reported COVID-19-like symptoms. The 
estimated prevalence was higher in the young, in smokers, and in Lombardy over the period 20 March to 7 April. 
Although the influenza season was ended by mid-March, at least part of the symptoms may be not COVID-19 
related. Even assuming that only half are, at least 7% of Italians and 10% in Lombardy had been affected by 
COVID-19. To these, asymptomatic or pauci-symptomatic cases have to be added. These estimates are at least 
one or two order of magnitude larger than official registered cases. This has major implications for cancer 
prevention, management and treatment. 
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Several thousand COVID-19 infected patients were projected in Italy by mid-March (Remuzzi and 
Remuzzi, 2020), and registered COVID-19 cases were over 110,000 by the end of March (Boccia et al., 
2020). 
Italy, and its largest region, Lombardy (with 10 million inhabitants), have been also subsequently heavily 
hit by the COVID-19 epidemic.  According to official data (Protezione Civile, 2020), up to 21 April 183,857 
cases and 24,648 deaths were registered in Italy. Corresponding figures for Lombardy were over 67,931 
cases and over 12,579 deaths. 
The COVID pandemic has substantial health implications besides its direct effects on population 
morbidity and mortality (Rosenbaum, 2020). Cancer screening, diagnosis and management have been 
heavily affected by the current pandemic, and it is therefore important to provide figures on COVID 
cases and deaths, in order to provide a perspective for the evolution of the pandemic and its potential 
implications on cancer patients (Nelson, 2020; Vrdoljak E et al., 2020). Each year, in Italy, about 180,000 
cancer deaths are registered, corresponding to over 350,000 incident and 2 million prevalent cases 
(Santucci C et al., 2020). These figures have to be put in perspective with the current COVID cases, 
deaths and hospital burden. 
The real number of COVID cases is however undefined, and in Italy registered cases include essentially 
hospital admissions, plus a small number of positive subjects from non-organized PCR tampons. 
To obtain an estimate of possible number of cases, we included a series of questions on COVID-19 
related symptoms (including fever, headache, cold, cough, gastrointestinal disorders -plus, separately, 
fever over 38.5 degrees Celsius), in two weekly national survey routinely conducted by BVA-Doxa. The 
first survey was conducted on March 27-30, and based on a sample of 1000 individuals, representative 
of the general Italian population aged 18-85 in terms of sex, age, geographic area and socio-economic 
status. Of these, 169 subjects were resident in Lombardy.  The second survey, was conducted on April 
3 to 7, using a different sample identified with the same criteria also included 1000 subjects, 184 from 
Lombardy. Thus, the two waves combined cover the period 20 March to 7 April. The data were collected 
using computer assisted web interviews (CAWI), and related to the three weeks preceding data 
collection. Confidence intervals of percentage estimates were based on the binomial distribution. We 
also computed the odds ratios (OR), and the corresponding 95% confidence intervals (CI) of reporting 
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COVID-19 like symptoms, including terms for sex, age, smoking, education, wave of interview, and area 
of residence. 
The key findings are given in the Table 1. In Italy, 14.2% of subjects reported some COVID-19-like 
symptoms, and 1.3% fever over 38.5 degrees over the last 2 weeks. Corresponding figures for Lombardy 
were 19.6% for any symptom, and 2.3% for fever over 38.5 degrees Celsius. Both in Italy and in 
Lombardy, the proportion of subjects reporting COVID-19-like symptoms was higher in women than in 
men, at younger age than in middle age and the elderly, in smokers than in nonsmokers, and in subjects 
with higher education. For age and smoking, the differences were significant. 
Table 2 gives the corresponding multivariate ORS. These were 2.0 (95% CI 1.5-2.8) for the young vs the 
elderly, 1.6 (95% CI 1.2-2.1) for smokers vs nonsmokers, and 1.7 (95% CI 1.2-2.3) for Lombardy ves other 
Italian regions. 
At least part of the symptoms reported are not COVID-19 related. Although the annual flu season had 
ended by mid-March – and was particularly moderate the last winter - , part of the symptoms reported 
may well be related to other, non-specific (viral) conditions. It is possible, however, that a considerable 
proportion of symptoms – and most of fever over 38.5 degrees in March and early April – were due to 
COVID-19. Even assuming that only about half of reported symptoms were due to COVID-19, over 7% 
of the population in Italy and 10% in Lombardy would have been affected by COVID-19 in the weeks 
covered by data collection only. This would correspond to at least 5 million subjects affected in Italy, 
and 1 million in Lombardy alone, a figure that can be doubled assuming that most COVID-19-like 
symptoms are indeed COVID-19 related. The information was restricted to a 2-week period, and 
additional subjects likely had been affected before 20 March. In addition, an undefined proportion of 
the population has been affected by totally or minimally symptomatic, COVID-19, and were not 
reported in our survey.  
While the key limitation of the survey is its subjective, self-reporting of symptoms, it has the strength 
of being included in a routinely weekly conducted, validated survey, of being reasonably large, and 
representative of the general population of Italy and Lombardy. 
The larger proportion of symptoms at younger age likely reflects more active social interactions in this 
age group. 
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These data indicate therefore that – even ignoring asymptomatic cases – the COVID-19 epidemic may 
well have affected a substantial proportion of the Italian population by early April, certainly at least one 
order of magnitude larger, and possibly up to two order of magnitude larger, than the registered cases. 
Still, these estimates remain far from those required to reach adequate natural immunity on a 
population level, and indicate therefore that the COVID pandemic is going to persist in Italy at least for 
the next couple of months. 
This would, therefore, imply unique challenges to the diagnosis and management of other diseases, 
including cancer. 
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Table 1  
Prevalence (%) and 95% confidence intervals of Covid19-like symptoms in the last three weeks in a 
representative sample of the Italian population.  BVA-Doxa, Italian national surveys, 27-30 March and 3- 7 
April 2020. 
       
Italy (N,%) 
N=2000 
 Lombardy (%) 
N=353 
 N (yes/no) % Yes  N (yes/no) % Yes 
Covid19-like symptoms  283/1717 14.2 
(12.6-15.7) 
 69/284 19.6 
(12.8-25.0)- 
      
Fever >38.5°C 26/1974 1.3 
(0.8-1.8) 
 8/345 2.3 
(0.9-4.42) 
      
Any symptom by strata 
      
Sex      
   Men  133/828 13.8  30/142 17.4 
   Women 150/889 14.4  39/142 21.6 
 p=0.70   p=0.33  
Age       
   18-44 148/624 19.2  40/91 30.5 
   45-64  79/610 11.5  15/115 11.5 
   65-85 56/483 10.4  14/78 15.2 
 p-trend<0.0001   p-trend=0.0017  
Smoking      
   No 172/1218 12.4  41/210 16.3 
   Yes 111/499 18.2  28/74 27.5 
 p=0.0006   p=0.02  
Educational level      
   Middle school or less 36/231 13.5  6/40 13.0 
   High school 135/894 13.1  37/150 19.8 
   University 112/592 15.9  26/94 21.7 
 p-trend=0.17   p-trend=0.25  
Wave of interview      
   27-31 March 144/856 14.4  31/138 18.3 
   3-7 April 139/861 13.9  38/146 20.7 
 P=0.75   P=0.59  
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Table 2  
Prevalence odds ratio and 95% confidence intervals of COVID-19-like symptoms in the last three weeks in a 
representative sample of the Italian population. BVA-Doxa, Italian national surveys 27-30 March and 3-7 
April 2020. 
 
 ORa (95% CI) 
Sex  
   Men  1 (ref) 
   Women 1.03 (0.80-1.34) 
Age   
   18-44 2.02 (1.45-2.82) 
   45-64  1.10 (0.76-1.59) 
   65-85 1 (ref) 
Smoking  
   No 1 (ref) 
   Yes 1.62 (1.24-2.11) 
Educational  level  
   Middle school or less 1 (ref) 
   High school 0.97 (0.65-1.44) 
   University 1.17 (0.77-1.77) 
Wave of interview  
   27-31 March 1 (ref) 
   3-7 April 0.94 (0.73-1.21) 
Area of residence  
   Lombardy 1.7 (1.24-2.28) 
    Other 1 (ref) 
a Estimated from a logistic model including all the terms above. 
 
 
  
 
